Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

VRTX - Vertex Pharmaceuticals, Inc.


IEX Last Trade
495.58
2.230   0.450%

Share volume: 1,809,551
Last Updated: Fri 30 Aug 2024 09:59:59 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology): 0.21%

PREVIOUS CLOSE
CHG
CHG%

$493.35
2.23
0.45%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 2022-09-30 2022-12-31 2023-03-31 2023-06-30 2023-09-30 2023-12-31 2024-03-31 2024-06-30
Fiscal Quarter Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024
Report Date 2022-10-28 2023-02-10 2023-05-02 2023-08-02 2023-11-07 2024-02-15 2024-05-07 2024-08-02
Assets
Total Assets 16.706 B 18.151 B 18.974 B 20.349 B 21.726 B 22.730 B 23.917 B 20.132 B
Current Assets 12.271 B 13.235 B 12.966 B 13.873 B 14.696 B 14.144 B 13.289 B 8.942 B
Inventories 388.200 M 460.600 M 535.100 M 603.500 M 688.700 M 738.800 M 813.100 M 914.600 M
Other Current Assets 726.900 M 553.500 M 468.700 M 476.900 M 540.200 M 623.700 M 511.100 M 575.400 M
Short Term Investments 726.900 M 553.500 M 468.700 M 476.900 M 540.200 M 623.700 M 511.100 M 575.400 M
Total Receivables 1.385 B 1.442 B 1.548 B 1.556 B 1.539 B 1.563 B 1.793 B 1.656 B
Current Cash 9.771 B 10.779 B 10.414 B 11.236 B 11.928 B 11.218 B 10.171 B 5.796 B
Total Non-current Assets 4.435 B 4.916 B 6.009 B 6.476 B 7.030 B 8.586 B 10.629 B 11.191 B
Property Plant Equipment 1.119 B 1.108 B 1.112 B 1.122 B 1.124 B 1.159 B 1.173 B 1.201 B
Other Assets 132.500 M 521.800 M 328.900 M 344.100 M 376.600 M 796.700 M 801.400 M 915.600 M
Intangible Assets 603.600 M 603.600 M 603.600 M 603.600 M 603.600 M 839.900 M 834.900 M 837.500 M
Goodwill 1.075 B 1.088 B 1.088 B 1.088 B 1.088 B 1.088 B 1.088 B 1.088 B
Liabilities and shareholders’ equity
Total Liabilities and shareholders’ equity 16.706 B 18.151 B 18.974 B 20.349 B 21.726 B 22.730 B 23.917 B 20.132 B
Total liabilities 3.677 B 4.238 B 4.542 B 4.879 B 5.213 B 5.150 B 5.371 B 5.357 B
Total current liabilities 2.609 B 2.742 B 3.026 B 3.352 B 3.599 B 3.547 B 3.796 B 3.547 B
Accounts Payable 126.900 M 303.900 M 323.200 M 363.000 M 375.900 M 364.900 M 351.400 M 327.900 M
Other liabilities 242.900 M 685.800 M 726.500 M 759.300 M 869.300 M 877.700 M 853.600 M 876.800 M
Current long term debt 0.000 40.800 M 0.000 0.000 0.000 50.600 M 0.000 0.000
Long term debt 442.300 M 430.800 M 417.600 M 404.100 M 390.300 M 376.100 M 361.500 M 346.600 M
Other liabilities 242.900 M 685.800 M 726.500 M 759.300 M 869.300 M 877.700 M 853.600 M 876.800 M
Minority interest 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Total Shareholder equity 13.030 B 13.913 B 14.432 B 15.470 B 16.513 B 17.580 B 18.547 B 14.775 B
Common stock 256.500 M 256.900 M 257.400 M 257.700 M 258.000 M 257.700 M 258.200 M 258.100 M
Retained earnings 5.704 B 6.523 B 7.223 B 8.138 B 9.174 B 10.142 B 11.242 B 7.648 B